United Therapeutics UTHR
NASDAQ UTHR
$506.95 +8.98 (+1.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

United Therapeutics (UTHR) Revenue Growth (3y) (2012 - 2026)

Analysis

United Therapeutics (UTHR) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 5.56%
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 7.01%
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 3.37%
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 8.00%
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 4.95%
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 7.50%
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 20.59%
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 9.51%
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 28.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.51%
Mar 31, 2026 15.52%
Dec 31, 2025 17.15%
Sep 30, 2025 15.71%
Jun 30, 2025 19.59%
Mar 31, 2025 19.81%
Dec 31, 2024 21.02%
Sep 30, 2024 18.97%
Jun 30, 2024 16.99%
Mar 31, 2024 21.37%
Dec 31, 2023 16.89%
Sep 30, 2023 17.04%
Jun 30, 2023 18.11%
Mar 31, 2023 12.47%
Dec 31, 2022 16.47%
Sep 30, 2022 8.72%
Jun 30, 2022 7.71%
Mar 31, 2022 8.40%
Dec 31, 2021 2.87%
Sep 30, 2021 2.52%